Pharmagy ApS: Financial statements 2022
CVR: 41488514
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
Pharmagy ApS (CVR 41488514) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 2,666,390 and a net result of DKK 731,124. Equity in the 2022 report amounted to DKK 1,299,045. The solvency ratio was 85.5%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,666,390
- Profit/Loss
- DKK 731,124
- Equity
- DKK 1,299,045
- Total Assets
- DKK 1,519,358
- Employees
- 2
Official annual report
Keep an eye on Pharmagy ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Pharmagy ApS has published its interim report for the period July 3, 2020 to December 31, 2021.
As of February 7, 2022, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of Pharmagy ApS.
About Pharmagy ApS
Pharmagy ApS is a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2020. The company is registered under the industry Computerkonsulentbistand og forvaltning af computerfaciliteter. The management consists of Kirsten Bjerrum and Lars Bøndergaard. The company is owned by LKSynergy ApS. The company has 2 employees (2026). In 2025, the company reported a gross profit of DKK 3,097,834 and a net result of DKK 966,279 compared with DKK 1,080,195 the year before. Equity in the 2025 report amounted to DKK 3,553,305.